Product
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report PIC packaging must deliver both high-density electrical connections and unobstructed optical access — discover why co-packaged optics are critical for data center scaling.
Article | Report Explore the 2026 technology landscape for bioreactor design in cell therapy manufacturing—covering perfusion systems, 3D scaffolds, AI process control, and CAR-T scale-up.
Article | Report AAV gene therapy vs. intravitreal injection for neovascular retinal disease: patent signals, durability data, delivery routes, and pipeline analysis from PatSnap Eureka.
Article | Report PIC packaging must deliver both high-density electrical connections and unobstructed optical access. Discover how co-packaged optics is reshaping data center scaling.
Article | Report Explore the 2026 freeform optics manufacturing patent landscape: liquid solidification, laser refractive index writing, AR/VR, automotive, and EUV applications.
Article | Report How does CGM sensor drift occur and how is it corrected? Explore enzymatic degradation, PISA artifacts, factory calibration, ML models, and the key patent holders shaping next-gen glucose monitoring.
Article | Report How does CGM sensor drift occur and how is it corrected? Explore enzymatic degradation, pressure artifacts, factory calibration, ML models, and patent trends from Dexcom, Medtronic, and more.
Article | Report Ultrafast laser microfabrication patent landscape 2026: femtosecond & picosecond laser trends across semiconductor packaging, biomedical, TPP, and beam shaping.
Article | Report Ex vivo lentiviral gene therapy for Wiskott-Aldrich syndrome and primary immunodeficiencies: vector design, HSPC transduction, clinical signals, and pipeline analysis.
Article | Report Patent evidence maps the 2026 permanent magnet motor landscape: MTPA/MTPV control, variable magnetization, sensorless drives, and magnet health prognostics across EV, aerospace, and industrial domains.
Article | Report Patent-driven analysis of permanent magnet motor technology in 2026: rotor architecture, MTPA/MTPV control, sensorless drives, and magnet health monitoring trends.
Article | Report How TERN-701 and asciminib target the ABL myristoyl pocket to overcome T315I resistance in CML — patent landscape, ASCEMBL data, and pipeline analysis.
Article | Report 80+ patents mapped: discover how polymer science, active electronics, and biologics are reshaping the implantable drug delivery device landscape in 2026.
Article | Report Analyse 80+ patents (2000–2026) mapping implantable drug delivery device technology clusters, top assignees, application domains, and emerging directions for 2026.
Article | Report How tabelecleucel and allogeneic EBV-specific T cell therapy are reshaping the post-transplant lymphoproliferative disease pipeline. Patent analysis & clinical signals.